The Role of Artificial Intelligence in Nephrology Clinical Trials
1The Charles Bronfman Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 2The Division of Data Driven and Digital Medicine (D3M), Icahn School of Medicine at Mount Sinai, New York, NY 3The Barbara T Murphy Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, NY aCorresponding Author: Girish N Nadkarni, MD, MPH, One Gustave L Levy Place, Box 1003, New York, NY-10029. [email protected]
Authors
- Girish N. Nadkarni (ORCID: https://orcid.org/0000-0001-6319-4314)
- Lili Chan (ORCID: https://orcid.org/0000-0003-4300-5760)
Institutions
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Journal of the American Society of Nephrology
- Published
- 2024-08-13
- DOI
- https://doi.org/10.1681/asn.0000000000000486
- Citations
- 1
- Primary Topic
- Artificial Intelligence in Healthcare and Education
- Type
- article
- Field-Weighted Citation Impact
- 0.12
Funders
- National Heart, Lung, and Blood Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
- Division of Diabetes, Endocrinology, and Metabolic Diseases